Project Grant HT94252310366
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$975K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This $390,000 Formula Grant award under the Military Medical Research and Development (CFDA 12.420) program, administered by the Defense Health Agency, supports research by The Trustees of the University of Pennsylvania on exploiting synthetic essential genetic dependencies to define oncogenic signaling networks and establish novel targets for lung adenocarcinoma therapy. The 1-year project period runs from March 2025 to March 2026 and focuses on advancing fundamental and applied research to...
The Pennsylvania State University will receive $979,599 from the Defense Health Agency through September 1, 2023 to August 31, 2026 under the Military Medical Research and Development federal grant program (CFDA 12.420). The project aims to develop a novel approach to target metabolic vulnerabilities in metastatic lung cancer. Through this funding, Penn State researchers will investigate medical solutions for cancer on the battlefield and transform healthcare for service members and the public...
The Trustees of the University of Pennsylvania received a $296,595 Project Grant award from the Department of the Army Medical Command on September 15, 2022 to complete work by September 14, 2025. The grant supports the "Controlling the Burden of Metastatic Disease in Pancreatic Ductal Adenocarcinoma" project conducted in Philadelphia, PA under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through...
This Project Grant award of $1,625,000 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports in-vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer at the Trustees of the University of Pennsylvania. The research aims to advance scientific understanding and develop solutions for this important health challenge. The award commenced on September 1, 2023 and is scheduled for completion by August 31, 2027. As a...
The Trustees of the University of Pennsylvania were awarded a $495,379 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2024 to target hepatocyte-derived factors in order to improve the efficacy of immunotherapy for pancreatic cancer. The Military Medical Research and Development program aims to transform health care for service members and the public...
The Trustees of the University of Pennsylvania received a $547,361 Project Grant award from the Department of the Army Medical Command to identify the histological and molecular constraints imposed by RB during therapy-induced small cell transformation. The award period runs from August 1, 2022 to July 31, 2024. The grant supports basic and applied biomedical research under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public...
The Trustees of the University of Pennsylvania were awarded a $1,624,578 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the mechanisms of mammary tumor recurrence from July 1, 2021 to June 30, 2024. Through this funding, the University of Pennsylvania will investigate medical solutions for breast cancer recurrence on the battlefield and for the American public...
The University of Pennsylvania, through its Clinical Practices division, was awarded a $812,500 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting UGCG in the Melanoma Tumor Microenvironment." This 3-year research project, which commenced on September 1, 2024, aims to investigate innovative approaches to treating melanoma, a serious form of skin cancer, with a focus on modulating the tumor...
This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
The Trustees of the University of Pennsylvania will receive $568,750 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2025 to develop treatment of chondrosarcoma, a type of bone cancer, using YAP siRNA nanoparticles in a novel mouse model of chondrosarcoma. The Military Medical Research and Development program (CFDA 12.420) supports basic, applied,...